Viewpoint
Inhaler Price Caps—Patchwork Progress Without Reform
JAMA Internal Medicine 10.1001/jamainternmed.2025.6321November 24, 2025 at 11:00 AM EST
This Viewpoint describes the public health implications of high inhaler costs for patients with asthma and chronic obstructive pulmonary disease.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.